Sickle-Cell Anemia: The Known and the Unknown

  1. SAMUEL CHARACHE, M.D., F.A.C.P.
  1. Department of Medicine, Johns Hopkins University School of Medicine,
    Baltimore, Md.

    Excerpt

    Sickle-cell anemia has become a topic of intense public interest; newspaper columnists, college students, baseball players, and Marcus Welby have devoted attention to it. The Congress has also paid attention, and it seems possible that more than 100 million dollars will be appropriated to "fight" this disease. Contrary to public opinion, research in this area has not been lacking in the past, although the anticipated influx of money has awakened much new interest. We now understand more about the pathogenesis of the illness, from molecule to man, than we do about that of almost any other disease (1). Like many

    This 100-word excerpt has been provided in the absence of an abstract.

    | Table of Contents
    Most Read Most Read
    Most Commented Most Commented On
    Annals in the News Annals in the News
    Clinical Trials Clinical Trials
    Comparative Effectiveness Comparative Effectiveness
    Hospital Medicine Hospital Medicine
    • Advertisement
    • Advertisement